Atrial Fibrillation (AF) Diagnostics Market to Record an Exponential CAGR by 2025
April 12, 2018 at 20:52 PM EDT
Albany, NY -- (SBWIRE) -- 04/12/2018 -- Condition in which irregular and rapid heart rate results in poor blood supply to the body is referred as arterial fibrillation (AF). In this condition, the atrial chambers do not beat in coordination with ventricles of heart. Atrial fibrillation shows symptoms such as rapid and irregular heart rate, palpitation, weakness, exercise intolerance, edema, shortness of breath and sometimes angina symptoms. Atrial fibrillation is classified based on symptoms such as first detected atrial fibrillation where only one episode is diagnosed, paroxysmal atrial fibrillation where recurrent episodes and self terminate in less than seven days, persistent atrial fibrillation where episodes are recurrent and last more than seven days and permanent atrial fibrillation where long term occurrence of episode takes place. Though atrial fibrillation is commonly associated with cardiac diseases, healthy heart can also suffer atrial fibrillation. Cardiac diseases linked to atrial fibrillation include, hypertension, mitral stenosis, coronary artery disease and congenital heart diseases. In addition lung diseases such as lung cancer, sarcoidosis, pneumonia, asthma, diabetes and heavy alcohol consumption are some of the other conditions that may result in atrial fibrillation. Family history of atrial fibrillation is another major factor that increases the disease risk in a person.